{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:59:06Z","timestamp":1740142746484,"version":"3.37.3"},"reference-count":54,"publisher":"Federa\u00e7\u00e3o das Associa\u00e7\u00f5es de Ginecologia e Obstetr\u00edcia","issue":"03","license":[{"start":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T00:00:00Z","timestamp":1555372800000},"content-version":"vor","delay-in-days":46,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev Bras Ginecol Obstet"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1055\/s-0039-1685482","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T23:11:05Z","timestamp":1555456265000},"page":"137-141","source":"Crossref","is-referenced-by-count":0,"title":["Widding the Use of Insulin Sensitizers to Patients with Polycystic Ovarian Syndrome\u2014A Late, but Wise Decision"],"prefix":"10.61622","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4813-6404","authenticated-orcid":false,"given":"Marcos Felipe","family":"Silva de S\u00e1","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Faculty of Medicine, Universidade de S\u00e3o Paulo, Ribeir\u00e3o Preto, SP, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"47794","published-online":{"date-parts":[[2019,4,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"issue":"07","key":"ref2","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.ijo.0801994","article-title":"Obesity and the polycystic ovary syndrome","volume":"26","author":"A Gambineri","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"01","key":"ref3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-277X.2010.01130.x","article-title":"Upper trunk fat assessment and its relationship with metabolic and biochemical variables and body fat in polycystic ovary syndrome","volume":"24","author":"F RO Penaforte","year":"2011","journal-title":"J Hum Nutr Diet"},{"issue":"03","key":"ref4","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.fertnstert.2004.01.041","article-title":"Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome","volume":"82","author":"E Carmina","year":"2004","journal-title":"Fertil Steril"},{"issue":"01","key":"ref5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.fertnstert.2011.11.026","article-title":"Do women with PCOS have a unique predisposition to obesity?","volume":"97","author":"K M Hoeger","year":"2012","journal-title":"Fertil Steril"},{"issue":"01","key":"ref6","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.fertnstert.2008.04.067","article-title":"Basal metabolic rate is decreased in women with polycystic ovary syndrome and biochemical hyperandrogenemia and is associated with insulin resistance","volume":"92","author":"N A Georgopoulos","year":"2009","journal-title":"Fertil Steril"},{"issue":"07","key":"ref7","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1210\/jc.2003-031583","article-title":"Ghrelin and measures of satiety are altered in polycystic ovary syndrome but not differentially affected by diet composition","volume":"89","author":"L J Moran","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"02","key":"ref8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/09513590400002300","article-title":"Impaired cholecystokinin secretion and disturbed appetite regulation in women with polycystic ovary syndrome","volume":"19","author":"A L Hirschberg","year":"2004","journal-title":"Gynecol Endocrinol"},{"issue":"06","key":"ref9","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1093\/ajcn\/86.5.1603","article-title":"Postprandial ghrelin, cholecystokinin, peptide YY, and appetite before and after weight loss in overweight women with and without polycystic ovary syndrome","volume":"86","author":"L J Moran","year":"2007","journal-title":"Am J Clin Nutr"},{"issue":"04","key":"ref10","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1530\/EJE-07-0683","article-title":"Ghrelin levels are suppressed and show a blunted response to oral glucose in women with polycystic ovary syndrome","volume":"158","author":"T M Barber","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"01","key":"ref11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neuropharm.2012.01.007","article-title":"CNS regulation of appetite","volume":"63","author":"J A Harrold","year":"2012","journal-title":"Neuropharmacology"},{"issue":"03","key":"ref12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.physbeh.2012.01.007","article-title":"Cognitive and neuronal systems underlying obesity","volume":"106","author":"S E Kanoski","year":"2012","journal-title":"Physiol Behav"},{"issue":"S 02","key":"ref13","first-page":"161","article-title":"Postprandial response of ghrelin and PYY and indices of low-grade chronic inflammation in lean young women with polycystic ovary syndrome","volume":"59","author":"K Zwirska-Korczala","year":"2008","journal-title":"J Physiol Pharmacol"},{"issue":"11","key":"ref14","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1093\/humrep\/dev231","article-title":"Gastrointestinal hormone secretion in women with polycystic ovary syndrome: an observational study","volume":"30","author":"T Lin","year":"2015","journal-title":"Hum Reprod"},{"issue":"12","key":"ref15","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1210\/en.2005-0237","article-title":"Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively","volume":"146","author":"N M Neary","year":"2005","journal-title":"Endocrinology"},{"issue":"07","key":"ref16","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1210\/jc.2008-0115","article-title":"Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome","volume":"93","author":"K Elkind-Hirsch","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"05","key":"ref17","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1507\/endocrj.EJ14-0602","article-title":"Efficacy and safety of liraglutide monotherapy compared with metformin in Japanese overweight\/obese patients with type 2 diabetes","volume":"62","author":"K Tanaka","year":"2015","journal-title":"Endocr J"},{"issue":"06","key":"ref18","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/cen.13454","article-title":"Efficacy of exenatide on weight loss, metabolic parameters and pregnancy in overweight\/obese polycystic ovary syndrome","volume":"87","author":"X Liu","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"06","key":"ref19","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.1365-2265.2008.03285.x","article-title":"Metformin increases fasting plasma peptide tyrosine tyrosine (PYY) in women with polycystic ovarian syndrome (PCOS)","volume":"69","author":"T Tsilchorozidou","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"02","key":"ref20","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1677\/joe.1.05866","article-title":"Appetite control","volume":"184","author":"K Wynne","year":"2005","journal-title":"J Endocrinol"},{"issue":"08","key":"ref21","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.2337\/diabetes.50.8.1714","article-title":"A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans","volume":"50","author":"D E Cummings","year":"2001","journal-title":"Diabetes"},{"issue":"10","key":"ref22","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/BF03349222","article-title":"Total ghrelin levels during acute insulin infusion in patients with polycystic ovary syndrome","volume":"30","author":"D Micic","year":"2007","journal-title":"J Endocrinol Invest"},{"issue":"10","key":"ref23","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1210\/jc.2002-020505","article-title":"Circulating ghrelin levels in patients with polycystic ovary syndrome","volume":"87","author":"C Sch\u00f6fl","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"03","key":"ref24","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1055\/s-2004-814341","article-title":"Elevated ghrelin plasma levels in patients with polycystic ovary syndrome","volume":"36","author":"R Wa\u015bko","year":"2004","journal-title":"Horm Metab Res"},{"issue":"08","key":"ref25","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1177\/1933719114522521","article-title":"Imbalance between postprandial ghrelin and insulin responses to an ad libitum meal in obese women with polycystic ovary syndrome","volume":"21","author":"C C Japur","year":"2014","journal-title":"Reprod Sci"},{"issue":"08","key":"ref26","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/sj.ijo.0802661","article-title":"Dietary intake, physical activity, and obesity in women with polycystic ovary syndrome","volume":"28","author":"C E Wright","year":"2004","journal-title":"Int J Obes Relat Metab Disord"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1146\/annurev.nutr.24.012003.132155","article-title":"The insulin resistance syndrome: definition and dietary approaches to treatment","volume":"25","author":"G M Reaven","year":"2005","journal-title":"Annu Rev Nutr"},{"issue":"04","key":"ref28","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1139\/h06-007","article-title":"Effects of exercise and nutritional counseling in women with polycystic ovary syndrome","volume":"31","author":"B Bruner","year":"2006","journal-title":"Appl Physiol Nutr Metab"},{"issue":"06","key":"ref29","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1043-2760(02)00612-4","article-title":"The role of lifestyle modification in polycystic ovary syndrome","volume":"13","author":"R J Norman","year":"2002","journal-title":"Trends Endocrinol Metab"},{"issue":"01","key":"ref30","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1055\/s-2007-992929","article-title":"Exercise therapy in polycystic ovary syndrome","volume":"26","author":"K M Hoeger","year":"2008","journal-title":"Semin Reprod Med"},{"issue":"12","key":"ref31","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1210\/jc.2005-1490","article-title":"The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery","volume":"90","author":"H F Escobar-Morreale","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"06","key":"ref32","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"A Dunaif","year":"1997","journal-title":"Endocr Rev"},{"issue":"01","key":"ref33","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/jc.2005-1329","article-title":"Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome","volume":"91","author":"D A Ehrmann","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"09","key":"ref34","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.2337\/diabetes.51.9.2796","article-title":"Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women","volume":"51","author":"T A Buchanan","year":"2002","journal-title":"Diabetes"},{"issue":"06","key":"ref35","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"W C Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.fertnstert.2007.09.041","article-title":"Thessaloniki ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome","volume":"89","year":"2008","journal-title":"Fertil Steril"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/humrep\/der396","article-title":"Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Consensus on women's health aspects of polycystic ovary syndrome (PCOS)","volume":"27","year":"2012","journal-title":"Hum Reprod"},{"issue":"01","key":"ref38","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.fertnstert.2011.11.036","article-title":"Should all women with PCOS be treated for insulin resistance?","volume":"97","author":"J C Marshall","year":"2012","journal-title":"Fertil Steril"},{"issue":"05","key":"ref39","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/jc.2009-2724","article-title":"Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society","volume":"95","author":"R A Wild","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"ref40","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.4158\/EP15748.DSC","article-title":"American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease state clinical review: guide to the best practices in the evaluation and treatment of Polycystic Ovary Syndrome\u2013part 1","volume":"21","author":"N F Goodman","year":"2015","journal-title":"Endocr Pract"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1687-9856-2011-9","article-title":"of the Drug and Therapeutics Committee of the Pediatric Endocrine Society. State of the art review: emerging therapies: the use of insulin sensitizers in the treatment of adolescents with polycystic ovary syndrome (PCOS)","volume":"2011","author":"D H Geller","year":"2011","journal-title":"Int J Pediatr Endocrinol"},{"issue":"10","key":"ref42","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1210\/jc.2003-030617","article-title":"Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents","volume":"88","author":"M E Silfen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"01","key":"ref43","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1365-2125.2011.04063.x","article-title":"Unlicensed use of metformin in children and adolescents in the UK","volume":"73","author":"Y Hsia","year":"2012","journal-title":"Br J Clin Pharmacol"},{"issue":"04","key":"ref44","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2265.2007.02764.x","article-title":"Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome","volume":"66","author":"T M Barber","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"ref45","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.amjmed.2017.06.012","article-title":"From evidence based medicine to medicine based evidence","volume":"130","author":"R I Horwitz","year":"2017","journal-title":"Am J Med"},{"issue":"06","key":"ref46","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ajog.2008.09.010","article-title":"Use of metformin in polycystic ovary syndrome","volume":"199","author":"R Mathur","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"ref47","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1210\/jc.2008-0461","article-title":"The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials","volume":"93","author":"K Hoeger","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"06","key":"ref48","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1055\/s-0032-1328878","article-title":"Obesity and PCOS: implications for diagnosis and treatment","volume":"30","author":"R S Legro","year":"2012","journal-title":"Semin Reprod Med"},{"issue":"02","key":"ref49","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.amjmed.2007.09.016","article-title":"Meta-analysis: metformin treatment in persons at risk for diabetes mellitus","volume":"121","author":"S R Salpeter","year":"2008","journal-title":"Am J Med"},{"issue":"02","key":"ref50","first-page":"47","article-title":"[Should insulin resistance be always treated in Polycystic Ovary Syndrome?]","volume":"36","author":"J M Soares J\u00fanior","year":"2014","journal-title":"Rev Bras Ginecol Obstet"},{"issue":"03","key":"ref51","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"H J Teede","year":"2018","journal-title":"Fertil Steril"},{"issue":"11","key":"ref52","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1210\/en.2015-1159","article-title":"Hyperandrogenism and insulin resistance, not changes in body weight, mediate the development of endothelial dysfunction in a female rat model of Polycystic Ovary Syndrome (PCOS)","volume":"156","author":"A Hurliman","year":"2015","journal-title":"Endocrinology"},{"issue":"04","key":"ref53","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3797\/scipharm.1407-16","article-title":"Pioglitazone and endothelial dysfunction: pleiotropic effects and possible therapeutic implications","volume":"82","author":"M Radenkovi\u0107","year":"2014","journal-title":"Sci Pharm"},{"issue":"03","key":"ref54","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ajog.2017.06.003","article-title":"Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity","volume":"217","author":"R Romero","year":"2017","journal-title":"Am J Obstet Gynecol"}],"container-title":["Revista Brasileira de Ginecologia e Obstetr\u00edcia \/ RBGO Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journalrbgo.org\/article\/widding-the-use-of-insulin-sensitizers-to-patients-with-polycystic-ovarian-syndrome-a-late-but-wise-decision\/","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0039-1685482.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T20:51:29Z","timestamp":1721335889000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalrbgo.org\/article\/widding-the-use-of-insulin-sensitizers-to-patients-with-polycystic-ovarian-syndrome-a-late-but-wise-decision\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":54,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2019,4,16]]},"published-print":{"date-parts":[[2019,3]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0039-1685482","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0100-7203","1806-9339"],"issn-type":[{"type":"print","value":"0100-7203"},{"type":"electronic","value":"1806-9339"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}